Howard Marks - Oaktree Capital Management
Holding/activity history for BioXcel Therapeutics, Inc. (BTAI)
← All BTAI superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 241,188 | 0.01 | $1.34 | $323,193 | SEC | ||
| 2025 Q4 | 241,188 | 0.01 | $1.60 | $385,902 | SEC | ||
| 2025 Q3 | 241,188 | 0.01 | $2.56 | $617,443 | SEC | ||
| 2025 Q2 | 241,188 | 0.01 | Buy | 0.01 | $1.17–2.22 · VW $1.54i | $436,551 | SEC |
Price snapshot:
Current price$0.88
Avg. buy price$1.81
+/- since buy-51.26%
52-week low$0.74
52-week high$8.08